<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343145">
  <stage>Registered</stage>
  <submitdate>5/07/2011</submitdate>
  <approvaldate>11/07/2011</approvaldate>
  <actrnumber>ACTRN12611000715976</actrnumber>
  <trial_identification>
    <studytitle>The effects of applying perianal local anesthetics on patient comfort during visual examination of the last part of large intestine</studytitle>
    <scientifictitle>No effect of perianal application of topical anesthetics on patient comfort during non-sedated sigmoidoscopy: a randomized, placebo-controlled clinical trial</scientifictitle>
    <utrn>U1111-1122-5893</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Patients undergoing sigmoidoscopy without any sedation</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients were randomized to 3 groups according to perianal application of different topical agents 30 minutes before the procedure as follows: 
Group 1 - 5 mL of vaseline application (placebo) 
Group 2 - 5 mL of 2% lidocaine gel  
Group 3 - 5 ml of 2.5% lidocaine plus 2.5% prilocaine cream</interventions>
    <comparator>Vaseline was used as lubricant in the control group</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Patient anxiety: assessed by STAI Iand II scales</outcome>
      <timepoint>Before and after sigmoidoscopy</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Pain: assessed by Visual analogue Scale</outcome>
      <timepoint>Just before the procedure; at the time when scope is inserted, during the procedure at intervals of 5 minutes; at the time when scope is removed, before discharge</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>ASA I-II patients undergoing sigmoidoscopy without sedation</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Exclusion criteria were use of anti-anxiety medicine within 48 hours before the procedure, cognitive dysfunction, past history of having lower endoscopy or anal/colorectal or gynecological surgery and complaint of pain at the anal area precluding examination.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes</concealment>
    <sequence>Block randomization was used to keep the sample size of the groups similar and block size was set to 3. Random Allocation Software (Ver. 1.0.0) was used to allocate the patients into groups.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/11/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>175</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Prof. Mehmet Ayhan KUZU</primarysponsorname>
    <primarysponsoraddress>Ankara University, Faculty of Medicine
Department of Surgery
06100, Samanpazari, Ankara</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Mesa Hospital</fundingname>
      <fundingaddress>Yasam Caddesi No:5 
06510, Sogutozu, Ankara</fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethics Committee of Ankara University School of Medicine</ethicname>
      <ethicaddress>Ankara Universitesi Tip Fakultesi 
Morfoloji Yerleskesi
Sihhiye 06100 Ankara, TURKIYE</ethicaddress>
      <ethicapprovaldate>15/10/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Ministry of Health of Turkey Ethics Committee of General Directorate of Pharmaceuticals and Pharmacy</ethicname>
      <ethicaddress>Sogutozu Mahallesi 2176. Sokak No:5 
06520 Cankaya, Ankara, TURKIYE</ethicaddress>
      <ethicapprovaldate>20/09/2010</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Hasan Kutluk Pampal</name>
      <address>Gazi Universitesi Tip Fakultesi 
Anesteziyoloji ve Reanimasyon AD
06500, Besevler, Ankara</address>
      <phone>+905325569624</phone>
      <fax />
      <email>hpampal@gazi.edu.tr</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Hasan Kutluk Pampal</name>
      <address>Gazi Universitesi Tip Fakultesi 
Anesteziyoloji ve Reanimasyon AD
06500, Besevler, Ankara</address>
      <phone>+905325569624</phone>
      <fax />
      <email>hpampal@gazi.edu.tr</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Hasan Kutluk Pampal</name>
      <address>Gazi Universitesi Tip Fakultesi 
Anesteziyoloji ve Reanimasyon AD
06500, Besevler, Ankara</address>
      <phone>+905325569624</phone>
      <fax />
      <email>hpampal@gazi.edu.tr</email>
      <country>Turkey</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>